Recursion 19. Feb. 2026 Nvidia Dumped It, Cathie Wood Bought It. A Pharma Stock Is Splitting the Market. - Barron's
Recursion 25. Jan. 2026 Will Nvidia-Backed BioHive-2 and Big Pharma Alliances Redefine Recursion Pharmaceuticals' (RXRX) Narrative - Yahoo Finance
Recursion 1. Jan. 2026 Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. - The Motley Fool
Recursion 1. Dez. 2025 Recursion’s Incoming CEO on Turning AI Drugs Into Clinical Proof Points - Genetic Engineering and Biotechnology News
Recursion 21. Nov. 2025 Recursion seeks to deliver results, and a VC sees a wave of M&A coming - statnews.com
Recursion 21. Nov. 2025 Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results - statnews.com
Exscientia 26. Okt. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News - Quiver Quantitative
Exscientia 20. Okt. 2025 Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Exscientia 28. Mai 2025 The first test of Recursion's Exscientia move | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline